T Lymphoblastic Lymphoma — Trials

T Lymphoblastic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 18%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00501826	Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	recruiting	Phase 2	160	M.D. Anderson Cancer CenterOTHER	1	Jul 15, 2026	clinicaltrials
NCT07523555	Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies(ADAPT-HEM)	recruiting	Phase 1 / Phase 2	96	Beijing BiotechINDUSTRY	1	Apr 13, 2026